Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Dantrium Intravenous (dantrolene)
- etranacogene dezaparvovec
Interactions between your drugs
dantrolene etranacogene dezaparvovec
Applies to: Dantrium Intravenous (dantrolene), etranacogene dezaparvovec
Etranacogene dezaparvovec can cause liver problems, which may make the medication less effective in treating your condition. Using other medications that can also affect the liver such as dantrolene after receiving etranacogene dezaparvovec may increase that risk. Symptoms of liver problems include fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark urine, pale stools, and/or yellowing of the skin or eyes. Blood tests to monitor liver function should be performed before and after treatment with etranacogene dezaparvovec. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
dantrolene food
Applies to: Dantrium Intravenous (dantrolene)
Alcohol can increase the nervous system side effects of dantrolene such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with dantrolene. Do not use more than the recommended dose of dantrolene, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Lioresal
Lioresal is used for chronic spasticity, muscle spasm, spasticity, spinal spasticity
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Botox Cosmetic
Botox Cosmetic temporarily improves the look of moderate to severe frown lines, crow's feet ...
Dantrium
Dantrium is used for chronic spasticity, malignant hyperthermia
Gablofen
Gablofen (baclofen) is used to treat severe spasticity. Includes Gablofen side effects ...
Fleqsuvy
Fleqsuvy is used for chronic spasticity, muscle spasm, spasticity, spinal spasticity
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.